Diabetic polyneuropathy: efficacy of Actovegin

Abstract

Diabetes mellitus (DM) is widespread all around the world; in the U.S., for example, diabetes was diagnosed in 12% of the population aged 60 and above, while in Europe - in 8-10% of the same population group. The prevalence of diabetes is growing, outstripping the worst predictions of the early 21st century; moreover, there is a "rejuvenation" of diabetes type 2. In diabetes mellitus, metabolic disorders caused by hyperglycemia and pathology of blood flow in the vessels of microcirculatory system lead to multiple lesions of the organs and systems of the body. Nephropathy, retinopathy and distal symmetric motor and sensory polyneuropathy (DSMSP) are the traditional complications of diabetes; DSMSP is the most frequent complication found in DM patients[1].

Keywords

• сахарный диабет
• осложнения
• полиневропатия
• актовегин
• diabetes mellitus
• complications
• polyneuropathy
• actovegin